Heron Therapeutics shares owned by Biltmore Family Office
Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Biltmore Family Office
from 13F filings
Historical chart of Biltmore Family Office investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Biltmore Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Heron Therapeutics by Biltmore Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $126k | 100k | 1.26 |
| 2025-06-30 | $210k | 102k | 2.07 |
| 2025-03-31 | $223k | 102k | 2.20 |
| 2024-12-31 | $155k | 102k | 1.53 |
| 2023-09-30 | $17k | 16k | 1.03 |
| 2023-06-30 | $19k | 16k | 1.16 |
| 2023-03-31 | $25k | 16k | 1.51 |